STAGED-PKD tests the hypothesis that GCS inhibition by venglustat, at a dose with a favorable safety and tolerability profile, may be a viable treatment to slow cyst growth and preserve kidney function in patients with rapidly progressing ADPKD. The gene discussed is UGCG; the disease is autosomal dominant polycystic kidney disease.